Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom (Nasdaq:DXCM) G7 15 ...

Medtronic (NYSE:MDT) announced the full U.S. launch for its Instinct sensor, made by Abbott, paired with the MiniMed 780G ...

MannKind (Nasdaq:MNKD) announced that the FDA accepted a supplemental New Drug Application (sNDA) for its Furoscix ReadyFlow ...

Abbott (NYSE:ABT) announced today that it issued a device correction for certain FreeStyle Libre 3 and Libre 3 Plus sensors ...

Insulet (Nasdaq:PODD) today hosted its Investor Day event, led by CEO Ashley McEvoy, laying out the future for the insulin ...

Ripple Therapeutics announced today that it entered into a deal with a Bausch + Lomb affiliate related to drug delivery ...

Embecta (Nasdaq:EMBC) today posted fourth-quarter financial results that proved mixed compared to the consensus forecast on ...

Dexcom announced today that it plans to launch its G7 15 Day continuous glucose monitor (CGM) in the U.S. next month.

PreEvnt aims for Isaac to help people with type 1, type 2 and pre-diabetes, reducing the need for or frequency of ...

Medtronic officials today said the planned separation of its Diabetes unit (MiniMed) is on track, with future offerings also ...

The Scotland-based company develops a novel pop-up cardboard dry powder inhaler (DPI). Rather than use expensive, bulky ...